Dallah Healthcare Company announced that its board of directors has approved the resignation of the board member, Dr. Fahad bin Abdulaziz Al-Rabiah, from the membership of the board of directors and compensation and remuneration committee, effective from November 15, 2022 due to his personal reasons.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
162.6 SAR | -0.25% | -3.33% | -5.36% |
Mar. 20 | Dallah Healthcare Company Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 14 | Dallah Healthcare Logs Higher FY23 Net Profit, Revenue | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.36% | 4.25B | |
-17.07% | 16.21B | |
+3.60% | 12.44B | |
+5.64% | 11.58B | |
+4.63% | 10.79B | |
+25.36% | 8.26B | |
-0.76% | 7.68B | |
+22.18% | 7.06B | |
+5.77% | 6.67B | |
+52.00% | 4.66B |
- Stock Market
- Equities
- 4004 Stock
- News Dallah Healthcare Company
- Dallah Healthcare Company Approves Resignation of Fahad Bin Abdulaziz Al-Rabiah as Board of Directors and Compensation and Remuneration Committee